Top 10 Producers in China’s Passenger Vehicle Industry by Sales Volume, 2016

Yuwenhao — Mon, 03 Jul 2017 04:00:33 +0000

Sales Volume Ranking of Top 10 Chinese Passenger Vehicle Producers, 2016 (10,000 cars)

Ranking	Enterprises	Sales Volume
1	SAIC Motor	221.89
2	Changan Automobile	135.41
3	Great Wall Automobile	96.89
4	DongFeng Automobile	89.64
5	BAIC Motor	87.39
6	Geely Auto	79.92
7	Chery Automobile	61.13
8	BYD	49.66
9	Guangzhou Automobile	37.62
10	JAC Motors	36.73
Total Sales Volume of Top 10 Producers	896.28
Total Sales Volume of Chinese Producers	1052.86
Proportion of Chinese Brands	85.13

Source: Internet

References:

China Passenger Vehicle Industry Overview, 2017-2021

In 2016, the output volume and sales volume of passenger vehicles in China were 24.421 million and 24.377 million, increasing by 15.5% and 14.9% over 2015, respectively.

A-share Listed Passenger Vehicle Companies – Profiles and Financial Data

In recent years, passenger vehicles have become an integral part of China’s automobile industry. The production volume and sales volume account for over 80% of all of China’s automobiles. In 2016, the production volume and sales volume reached 24.421 million and 24.377 million, increasing by 15.5% and 14.9% over…

The post Top 10 Producers in China’s Passenger Vehicle Industry by Sales Volume, 2016 first appeared on CRI Report.

Analysis on In-vitro Diagnostic (IVD) Reagent Industry in China, 2017

Yuwenhao — Tue, 27 Jun 2017 06:06:48 +0000

Global sales volume of medical technology (including medical apparatus and instruments, diagnostic products) will reach USD 440 billion with a growth rate of 4.4% by 2018. IVD industry holds the largest market share among all subdivided industries. It is estimated that the market share of IVD industry will reach USD 54.5 billion, accounting for 12.4% of the whole market. China’s IVD market will grow 10% in 5 years and its size will exceed USD 10 billion. However, imported instruments and reagents account for over 50% of domestic IVD market. As market demand for hospital accounts for over 90% of the total IVD demands, IVD industry will benefit from the increasing hospital visits and examination charges per capita. It is estimated that the growth rate will maintain between 16%-18%, a higher level.

At present, there are 1,199 IVD reagent producers in China. Producers of larger scale are as follows, Kehua Bio-engineering, DAAN Gene, Strong Biotechnologies, Leadman Biochemistry, Shenzhen Mindray, Sichuan Maker, Biosino Bio-technology, Fosun Long March, etc., among which Kehua Bio-engineering, DAAN Gene, Leadman Biochemistry, EPNK, etc. are the public companies.

Development Trend of IVD Reagent Technology

Biochemical Diagnosis

Emphasis will be put on improving stability of the previous examination products and developing new examination projects brought by technological progress. The trend of substituting imported biochemical diagnostic reagents with domestic ones will be further strengthened in the future.

Immunodiagnosis

Chemiluminescent reagents have high technical requirements, which will be the main technology of IVD reagents in the future. At present, China depends on imported chemiluminescent reagents, therefore it is an inevitable trend that China will research and develop chemiluminescent products to replace the imported ones.

Upstream Raw Materials

At present, China still mostly depends on imported upstream raw materials. From the long run, China must master the preparation techniques of raw materials.

Reference Reports:

Research Report on China In-vitro Diagnostic Reagent Industry, 2017-2021

In 2016, the annual consumption per capita of China’s in-vitro diagnostic products was less than USD 3, while that of developed countries reached USD 25 to USD 30.

The post Analysis on In-vitro Diagnostic (IVD) Reagent Industry in China, 2017 first appeared on CRI Report.